Company News Summary | 02 Dec 2019

Click the print icon in your browser to print this report. Currency is in AUD unless otherwise specified

Avita Medical Reports Negative Cash Flow of $7.34m for the September 2019 Quarter

18:42:00 | Associate analysts

Original annuncemenet:Appendix 4C Quarterly and Company Update

Avita Medical reported negative cash flow of $7.34m for quarter ended 30 September 2019. Operating cash flow for the period was $(7.04m). Investing cash flow was $(300,000). Financing cash flow was nil. Cash in hand at the end of the quarter was $22.66m.

Consolidated Statement of Cash Flow for the Quarter ended 30 September 2019

Current Quarter $A'000- 30 September 2019 Year to Date $A'000-3 Months
Net Operating Cash Flows (7,037) (7,037)
Net Investing Cash Flows (300) (300)
Total Operating and Investing Cash Flows (7,337) (7,337)
Net Financing Cash Flows 0 0
Net Increase (Decrease) in Cash Held (7,337) (7,337)
Cash at Beginning of Quarter/Year to Date 28,983 28,983
Cash at End of Quarter 22,656 22,656
This report appeared on 2020 Morningstar Australasia Pty Limited

© Copyright 2020 Morningstar Australasia Pty Ltd ABN: 95 090 665 544 ("Morningstar"), AFSL no 240892. (a subsidiary of Morningstar, Inc.). This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written content of Morningstar. Some of the material provided is published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO").

DISCLAIMER: To the extent that any of the content above constitutes advice, it is general advice that has been prepared without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain appropriate financial, legal and taxation advice before making any financial investment decision. If applicable, investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Please refer to our Financial Services Guide (FSG) for more information at FSG or phone Morningstar on 1800 03 44 55 to request a copy. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for any use or distribution of any of this information

DISCLOSURE: Employees may have an interest in the securities discussed in this report.